| 2 |
골대사 |
폐경후 골감소증 여성에서 sclerostin 항체인 blosozumab의 무작위 이중맹검 2상 임상 시험(A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density)
J Bone Miner Res 2014 Aug 28, Epub ahead of print
|